Search Results 451-460 of 8002 for TNF
The primary purpose of this research study is to collect a large enough sample of fat cells (preadipocytes) and blood from patients undergoing surgery to ...
This study is a placebo-controlled, double-blind, randomized trail enrolling children aged 2 to <6 years old with uncontrolled asthma and/or recurrent severe ...
The aim of this study is to better identify trends in trainee remediation and outcome in a large quaternary care academic institution, in an effort to improve ...
For more information about the Transgenic and Knockout Core or to discuss a potential project, contact: Darren Baker, Ph.D. Core Director. Do Young Lim, Ph.
Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as floxuridine, work in ...
To study the safety and effectiveness of multiple-doses of tralokinumab on pulmonary function in adults with mild to moderate idiopathic pulmonary fibrosis (IPF) ...
The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC patients, ...
Diagnosis and Management of Latent Tuberculosis and Tuberculosis in Candidates for TNF-alpha Antagonist Therapy: An Expert Survey J of Mycobac Dis.2014, Oct ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
A Study to Assess the Safety and Preliminary Effectiveness of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients with Newly ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.